Early Breast Cancer

AUG 18, 2026 · PHASE 3 TRIAL

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

ClinicalTrials.gov

This is a trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for assessment.

AUG 17, 2026 · PHASE 3 TRIAL

A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)

ClinicalTrials.gov

This is a Phase 3 trial registration with no results posted; the study is actively recruiting and primary outcomes have not yet been assessed.

JUL 31, 2026 · PHASE 3 TRIAL

Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests

ClinicalTrials.gov

This is an active Phase 3 RCT registration with no posted results; the study is recruiting and outcome data are not yet available, making any efficacy claim impossible.